Urine free cortisol in the diagnosis of Cushing's syndrome: Is it worth doing and, if so, how?

Journal of Clinical Endocrinology and Metabolism

Volumn 100, Issue 2, 2015, Pages 395-397

  Raff, Hershel ^a   Auchus, Richard J ^b   Findling, James W ^c   Nieman, Lynnette K ^d  

^a ST LUKE S MEDICAL CENTER   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c MEDICAL COLLEGE OF WISCONSIN   (United States)

^d EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; HYDROCORTISONE; SEX HORMONE;

CIRCADIAN RHYTHM; CORTICOSTEROID METABOLISM; CUSHING SYNDROME; DEXAMETHASONE SUPPRESSION TEST; DIAGNOSTIC VALUE; FALSE POSITIVE RESULT; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; HYDROCORTISONE URINE LEVEL; HYPERCORTISOLISM; IMMUNOASSAY; LIQUID CHROMATOGRAPHY; LOW DRUG DOSE; MASS FRAGMENTOGRAPHY; NEGATIVE FEEDBACK; NOTE; PRIORITY JOURNAL; SALIVA LEVEL; SCREENING TEST; SENSITIVITY AND SPECIFICITY; URINE FREE CORTISOL; MASS SPECTROMETRY;

GONADAL STEROID HORMONES; HUMANS; MASS SPECTROMETRY;

EID: 84922570731     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2014-3766     Document Type: Note

References (14)

1. Nieman LK, Biller BM, Findling JW, et al. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2008; 93(5): 1526-1540.
2. Alexandraki KI, Grossman AB. Isurinary free cortisol of value in the diagnosis of Cushing's syndrome? Curr Opin Endocrinol Diabetes Obes. 2011; 18(4): 259-263.
3. Handelsman DJ, Wartofsky L. Requirement for mass spectrometry sex steroid assays in the Journal of Clinical Endocrinology and Metabolism. J Clin Endocrinol Metab. 2013; 98(10): 3971-3973.
4. Nieman LK Screening for reversible osteoporosis: is cortisol a culprit? Ann Intern Med. 2007; 147(8): 582-584.
5. Raff H, Sharma ST, Nieman LK. Physiological basis for the etiology, diagnosis, and treatment of adrenal disorders: Cushing's syndrome, adrenal insufficiency, and congenital adrenal hyperplasia. Compr Physiol. 2014; 4(2): 739-769.
6. Raff H. Cushing's syndrome: diagnosis and surveillance using salivary cortisol. Pituitary. 2012; 15(1): 64-70.
7. Kidambi S, Raff H, Findling JW. Limitations of nocturnal salivary cortisol and urine free cortisol in the diagnosis of mild Cushing's syndrome. Eur J Endocrinol. 2007; 157(6): 725-731.
8. Petersenn S, Newell-Price J, Findling JW, et al. High variability in baseline urinary free cortisol values in patients with Cushing's disease. Clin Endocrinol (Oxf). 2014; 80(2): 261-269.
9. Samuels MH, Brandon DD, Isabelle LM, et al. Cortisol production rates in subjects with suspected Cushing's syndrome: assessment by stable isotope dilution methodology and comparison to other diagnostic methods. J Clin Endocrinol Metab. 2000; 85(1): 22-28.
10. Krone N, Hughes BA, Lavery GG, Stewart PM, Arlt W, Shackleton CH. Gas chromatography/mass spectrometry (GC/MS) remains a pre-eminent discovery tool in clinical steroid investigations even in the era of fast liquid chromatography tandem mass spectrometry (LC/MS/MS). J Steroid Biochem Mol Biol. 2010; 121: 496-504.
11. Kotłowska A, Sworczak K, Stepnowski P. Urine metabolomics analysis for adrenal incidentaloma activity detection and biomarker discovery. J Chromatogr B Analyt Technol Biomed Life Sci. 2011; 879: 359-363.
12. Wood L, Ducroq DH, Fraser HL, et al. Measurement of urinary free cortisol by tandem mass spectrometry and comparison with results obtained by gas chromatography-mass spectrometry and two commercial immunoassays. Ann Clin Biochem. 2008; 45: 380-388.
13. Erickson D, Singh RJ, Sathananthan A, Vella A, Bryant SC. Late-night salivary cortisol for diagnosis of Cushing's syndromeby liquid chromatography/tandem mass spectrometry assay. Clin Endocrinol (Oxf). 2012; 76(4): 467-472.
14. Carroll T, Raff H, Findling JW. Late-night salivary cortisol for the diagnosis of Cushing syndrome: a meta-analysis. Endocr Pract. 2009; 15(4): 335-342.